AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29266295 — intervention group
Group type: EXPERIMENTAL
Intervention: Lukewarm parenting profile (14 & 24 months)
Number of subjects: 2876
Study 29266295 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufficient parenting profile (36 months and pre-K)
Number of subjects: 2876
Study 29266295 — intervention group
Group type: EXPERIMENTAL
Intervention: Harsh parenting profile
Number of subjects: 2876
Study 29266295 — intervention group
Group type: EXPERIMENTAL
Intervention: Detached parenting profile
Number of subjects: 2876
Study 29266295 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression and family conflict
Number of subjects: 2876
Study 27101556 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg saffron capsule (Crocus sativus L. stigma) twice daily for 12 weeks
Number of subjects: 60
Study 27101556 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsule twice daily for 12 weeks
Number of subjects: 60
Study 24548574 — intervention group
Group type: COMPARATOR
Intervention: Obese women
Number of subjects: 160
Study 24548574 — intervention group
Group type: COMPARATOR
Intervention: Women with abdominal obesity
Number of subjects: 160
Study 21801467 — intervention group
Group type: EXPERIMENTAL
Intervention: Lingzhi (Ganoderma lucidum) 1.44 g daily for 12 weeks
Number of subjects: 26
Study 21801467 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 20842389 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 96
Study 20842389 — intervention group
Group type: COMPARATOR
Intervention: Multiple daily insulin injections (MDI)
Number of subjects: 96
Study 20842389 — intervention group
Group type: EXPERIMENTAL
Intervention: Both CSII and MDI
Number of subjects: 96
Study 20842389 — intervention group
Group type: EXPERIMENTAL
Intervention: CSII with insulin analogues
Number of subjects: 96
Study 19211470 — intervention group
Group type: EXPERIMENTAL
Intervention: Education on avoiding foods with phosphorus additives
Number of subjects: 279
Study 19211470 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 279
Study 15718180 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led intervention involving patient and family education about heart failure and self-management, and monthly telephone follow-up during 12 months by a primary health care nurse
Number of subjects: 153
Study 15718180 — intervention group
Group type: COMPARATOR
Intervention: Control group (details not specified)
Number of subjects: 153
Study 12855098 — intervention group
Group type: EXPERIMENTAL
Intervention: Lichtenstein tension‐free hernioplasty (LH)
Number of subjects: 17
Study 12855098 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic preperitoneal hernia (LPPH)
Number of subjects: 17
Study 10596882 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxycillin and clavulanic acid for 1 week post tonsillectomy (Group A)
Number of subjects: 78
Study 10596882 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Group B)
Number of subjects: 78
Study 8671790 — intervention group
Group type: EXPERIMENTAL
Intervention: Iloprost infusion (1 ng.kg-1.min-1)
Number of subjects: 10
Study 8671790 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 10
Study 8671790 — intervention group
Group type: EXPERIMENTAL
Intervention: Iloprost infusion
Number of subjects: 10
Study 8671790 — intervention group
Group type: COMPARATOR
Intervention: CsA ingestion (3 mg.kg-1)
Number of subjects: 10
Study 8671790 — intervention group
Group type: COMPARATOR
Intervention: Control clearance study without CsA intake or iloprost/placebo infusion
Number of subjects: 10
Study 1877813 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial infusion chemotherapy (IA)
Number of subjects: 41
Study 1877813 — intervention group
Group type: COMPARATOR
Intervention: Systemic chemotherapy (IV)
Number of subjects: 41
Study 6635913 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone-iodine wound irrigation
Number of subjects: 187
Study 6635913 — intervention group
Group type: COMPARATOR
Intervention: Normal saline solution
Number of subjects: 187
Study 31843844 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse navigator-led ACP pathway
Number of subjects: 765
Study 31843844 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 765
Study 30080229 — intervention group
Group type: EXPERIMENTAL
Intervention: Investigational product (Cerbella TM) consisting of an emulsified liquid combination of standardized fish oil, panax ginseng extract, and green tea catechins
Number of subjects: 10
Study 30080229 — intervention group
Group type: EXPERIMENTAL
Intervention: Investigational product (Cerbella TM)
Number of subjects: 10
Study 30080229 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 26950257 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio-based cognitive-behavioural therapy (CBT) program
Number of subjects: 24
Study 26950257 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (WL)
Number of subjects: 24
Study 24953481 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal Therapy (IPT)
Number of subjects: 0
Study 24953481 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication
Number of subjects: 0
Study 24953481 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 22098922 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Nissen fundoplication (LNF)
Number of subjects: 110
Study 22098922 — intervention group
Group type: COMPARATOR
Intervention: Open Nissen fundoplication (ONF)
Number of subjects: 110
Study 20180009 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention
Number of subjects: 226
Study 17469154 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (AZM)
Number of subjects: 0
Study 15244014 — intervention group
Group type: EXPERIMENTAL
Intervention: PureSperm density gradient method
Number of subjects: 121
Study 15244014 — intervention group
Group type: COMPARATOR
Intervention: Percoll density gradient method
Number of subjects: 121
Study 11700918 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality-of-life measurement using generic and specific instruments
Number of subjects: 0
Study 11700918 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality-of-life measurement using ad hoc instruments
Number of subjects: 0
Study 10189587 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG+ killed M. leprae
Number of subjects: 171400
Study 10189587 — intervention group
Group type: EXPERIMENTAL
Intervention: ICRC
Number of subjects: 171400
Study 10189587 — intervention group
Group type: EXPERIMENTAL
Intervention: M.w
Number of subjects: 171400
Study 10189587 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG
Number of subjects: 171400
Study 10189587 — intervention group
Group type: COMPARATOR
Intervention: Normal saline placebo
Number of subjects: 171400
Study 7827929 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 100 mg IV twice daily for 4 days, followed by 150 mg orally twice daily for 5 days
Number of subjects: 24
Study 7827929 — intervention group
Group type: COMPARATOR
Intervention: Control (no ranitidine)
Number of subjects: 24
Study 7827929 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 24
Study 3396164 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous streptokinase
Number of subjects: 368
Study 31109915 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Stepped Alcohol Treatment (ISAT)
Number of subjects: 128
Study 31109915 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 128
Study 28342828 — intervention group
Group type: EXPERIMENTAL
Intervention: Contralateral strength training (CST)
Number of subjects: 30
Study 28342828 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct strength training
Number of subjects: 30
Study 26667739 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 ml/day of extra virgin coconut oil
Number of subjects: 0
Study 26667739 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 0
Study 23315144 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone (various doses)
Number of subjects: 767
Study 21252731 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated milking of the cord (four times)
Number of subjects: 58
Study 21252731 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (cord clamping for 30 seconds)
Number of subjects: 58
Study 19724980 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 95
Study 19724980 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 95
Study 19724980 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study 17882149 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest tertile of fetuin-A levels
Number of subjects: 822
Study 17882149 — intervention group
Group type: EXPERIMENTAL
Intervention: Fetuin-A as a continuous variable
Number of subjects: 822
Study 15137930 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education intervention for 12 months
Number of subjects: 406
Study 15137930 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 406
Study 11822785 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg clodronate
Number of subjects: 26
Study 11822785 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 10181018 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-generated tailored letter on the outcomes of smoking cessation
Number of subjects: 246
Study 10181018 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-generated tailored letter containing self-efficacy enhancing information (skills)
Number of subjects: 246
Study 10181018 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no cessation information)
Number of subjects: 246
Study 8745495 — intervention group
Group type: EXPERIMENTAL
Intervention: Correction of abnormal fetal axis by hand in the study group (58 cases)
Number of subjects: 108
Study 8745495 — intervention group
Group type: COMPARATOR
Intervention: Control group (30 cases)
Number of subjects: 108
Study 2515724 — intervention group
Group type: EXPERIMENTAL
Intervention: Selegiline monotherapy
Number of subjects: 56
Study 2515724 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 893725 — intervention group
Group type: EXPERIMENTAL
Intervention: Reliability Enhancement
Number of subjects: 57
Study 893725 — intervention group
Group type: EXPERIMENTAL
Intervention: Truth Talk
Number of subjects: 57
Study 893725 — intervention group
Group type: COMPARATOR
Intervention: No Comment Control
Number of subjects: 57
Study 31891746 — intervention group
Group type: COMPARATOR
Intervention: 300 mg resveratrol
Number of subjects: 29
Study 31891746 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg resveratrol
Number of subjects: 29
Study 31891746 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 31220630 — intervention group
Group type: EXPERIMENTAL
Intervention: ERAS group
Number of subjects: 50
Study 31220630 — intervention group
Group type: COMPARATOR
Intervention: Conventional care group
Number of subjects: 50
Study 27594544 — intervention group
Group type: EXPERIMENTAL
Intervention: Suicide prevention program (twice a week for 5 weeks)
Number of subjects: 62
Study 27594544 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 62
Study 26999890 — intervention group
Group type: EXPERIMENTAL
Intervention: Utility arches (UA)
Number of subjects: 30
Study 26999890 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini-implants (MI)
Number of subjects: 30
Study 26999890 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 24459173 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehab (exercise and education classes for 60 minutes/day, twice weekly for at least four weeks)
Number of subjects: 17
Study 24459173 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehab
Number of subjects: 17
Study 24459173 — intervention group
Group type: COMPARATOR
Intervention: Standard care (three‐hour preassessment appointment)
Number of subjects: 17
Study 24459173 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 17
Study 20884383 — intervention group
Group type: EXPERIMENTAL
Intervention: Clamping P(ET)(CO₂)
Number of subjects: 10
Study 20884383 — intervention group
Group type: COMPARATOR
Intervention: Control (no clamping of P(ET)(CO₂))
Number of subjects: 10
Study 18818954 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftibuten 9 mg/kg once daily for 10 days
Number of subjects: 547
Study 18818954 — intervention group
Group type: COMPARATOR
Intervention: TMP‐SMX (3 mg + 15 mg)/kg twice daily for 10 days
Number of subjects: 547
Study 17571655 — intervention group
Group type: COMPARATOR
Intervention: Hand immersion in 20 degrees C water
Number of subjects: 6
Study 17571655 — intervention group
Group type: EXPERIMENTAL
Intervention: Forearm immersion in 20 degrees C water
Number of subjects: 6
Study 17571655 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand and forearm immersion in 10 degrees C water
Number of subjects: 6
Study 17571655 — intervention group
Group type: COMPARATOR
Intervention: Control (no immersion)
Number of subjects: 6
Study 15450766 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% mannitol 100 ml IV in 20 min
Number of subjects: 21
Study 15450766 — intervention group
Group type: COMPARATOR
Intervention: Sham infusion (control)
Number of subjects: 21
Study 11473962 — intervention group
Group type: EXPERIMENTAL
Intervention: rhFSH 150 IU ('low')
Number of subjects: 120
Study 11473962 — intervention group
Group type: EXPERIMENTAL
Intervention: rhFSH 225 IU ('high')
Number of subjects: 120
Study 9608379 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrust in Motion Cervical (TMC) manikin; experimental group (n = 6) practiced adjustive thrust only on the TMC manikin.
Number of subjects: 20
Study 9608379 — intervention group
Group type: COMPARATOR
Intervention: Established 'hands-on' approach; control group (n = 14) performed thrusting maneuvers on fellow student subjects.
Number of subjects: 20
Study 9608379 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups were supervised, taught and examined in an otherwise identical fashion.
Number of subjects: 20
Study 8015241 — intervention group
Group type: EXPERIMENTAL
Intervention: Maxaquin 400 mg once a day for 7-14 days
Number of subjects: 62
Study 8015241 — intervention group
Group type: COMPARATOR
Intervention: Ciprofloxacin 500 mg twice a day for 7-14 days
Number of subjects: 62
Study 8015241 — intervention group
Group type: EXPERIMENTAL
Intervention: Maxaquin
Number of subjects: 62
Study 8015241 — intervention group
Group type: COMPARATOR
Intervention: Ciprofloxacin
Number of subjects: 62
Study 8015241 — intervention group
Group type: EXPERIMENTAL
Intervention: Maxaquin and Ciprofloxacin
Number of subjects: 62
Study 2104811 — intervention group
Group type: EXPERIMENTAL
Intervention: Luteal phase supplementation with human chorionic gonadotropin (hCG) in Group A (n = 18)
Number of subjects: 36
Study 2104811 — intervention group
Group type: COMPARATOR
Intervention: None (Control) in Group B (n = 18)
Number of subjects: 36
Study 2104811 — intervention group
Group type: EXPERIMENTAL
Intervention: Luteal phase supplementation with hCG in Group A (n = 18)
Number of subjects: 36
Study 71970 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg flurbiprofen daily (tablet or liquid suspension)
Number of subjects: 40
Study 31679055 — intervention group
Group type: EXPERIMENTAL
Intervention: Schizophrenia
Number of subjects: 0
Study 31679055 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar Disorder
Number of subjects: 0
Study 31679055 — intervention group
Group type: EXPERIMENTAL
Intervention: Alzheimer's Disease
Number of subjects: 0
Study 31679055 — intervention group
Group type: COMPARATOR
Intervention: Genetic variants associated with schizophrenia, BD, and AD
Number of subjects: 0
Study 31165663 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor (180 mg loading dose)
Number of subjects: 117
Study 31165663 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor (90 mg BID for 30 days)
Number of subjects: 117
Study 31165663 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel (600 mg loading dose)
Number of subjects: 117
Study 31165663 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel (75 mg OD for 30 days)
Number of subjects: 117
Study 28621488 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) for quadriceps muscle, 8 weeks, 3 times/week (20-34 min) during HD sessions
Number of subjects: 21
Study 28621488 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 21
Study 25922838 — intervention group
Group type: EXPERIMENTAL
Intervention: Long protocol with combined oral contraceptive (OC) pills
Number of subjects: 298
Study 25922838 — intervention group
Group type: COMPARATOR
Intervention: Short agonist protocol with estradiol priming
Number of subjects: 298
Study 24148574 — intervention group
Group type: EXPERIMENTAL
Intervention: Web based MMR decision aid plus usual practice
Number of subjects: 220
Study 24148574 — intervention group
Group type: EXPERIMENTAL
Intervention: MMR leaflet plus usual practice
Number of subjects: 220
Study 24148574 — intervention group
Group type: COMPARATOR
Intervention: Usual practice only (control)
Number of subjects: 220
Study 21748205 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mcg/kg/min remifentanil infusion (Group R1)
Number of subjects: 86
Study 21748205 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.15 mcg/kg/min remifentanil infusion (Group R2)
Number of subjects: 86
Study 21748205 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (R1 and R2)
Number of subjects: 86
Study 19523012 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphenhydramine (i.v. microdose 0.1 mg)
Number of subjects: 0
Study 19523012 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphenhydramine (oral microdose 0.1 mg)
Number of subjects: 0
Study 19523012 — intervention group
Group type: EXPERIMENTAL
Intervention: NBI‐2 (oral microdose 0.1 mg)
Number of subjects: 0
Study 19523012 — intervention group
Group type: EXPERIMENTAL
Intervention: NBI‐1 (oral microdose 0.1 mg)
Number of subjects: 0
Study 19523012 — intervention group
Group type: EXPERIMENTAL
Intervention: NBI‐3 (oral microdose 0.1 mg)
Number of subjects: 0
Study 19523012 — intervention group
Group type: EXPERIMENTAL
Intervention: NBI‐4 (oral microdose 0.1 mg)
Number of subjects: 0
Study 19523012 — intervention group
Group type: EXPERIMENTAL
Intervention: NBI‐4 (i.v. microdose 0.1 mg)
Number of subjects: 0
Study 19523012 — intervention group
Group type: EXPERIMENTAL
Intervention: NBI‐1 (i.v. microdose 0.1 mg)
Number of subjects: 0
Study 19523012 — intervention group
Group type: EXPERIMENTAL
Intervention: NBI‐3 (i.v. microdose 0.1 mg)
Number of subjects: 0
Study 19523012 — intervention group
Group type: EXPERIMENTAL
Intervention: NBI‐2 (i.v. microdose 0.1 mg)
Number of subjects: 0
Study 16951472 — intervention group
Group type: EXPERIMENTAL
Intervention: Parathyroid hormone (PTH)
Number of subjects: 0
Study 16951472 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate
Number of subjects: 0
Study 16951472 — intervention group
Group type: EXPERIMENTAL
Intervention: PTH and raloxifene (combined treatment)
Number of subjects: 0
Study 16951472 — intervention group
Group type: COMPARATOR
Intervention: Strontium ranelate
Number of subjects: 0
Study 16382122 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen 5 mg/d
Number of subjects: 235
Study 16382122 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenretinide 200 mg/d
Number of subjects: 235
Study 16382122 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen plus Fenretinide
Number of subjects: 235
Study 16382122 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 235
Study 16382122 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 235
Study 16382122 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenretinide
Number of subjects: 235
Study 16382122 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment arms
Number of subjects: 235
Study 12730811 — intervention group
Group type: EXPERIMENTAL
Intervention: Water soluble vitamin E (100 mg)
Number of subjects: 30
Study 12730811 — intervention group
Group type: COMPARATOR
Intervention: Tepid saline (control)
Number of subjects: 30
Study 10503858 — intervention group
Group type: EXPERIMENTAL
Intervention: Face pad pressure dressing
Number of subjects: 47
Study 10503858 — intervention group
Group type: COMPARATOR
Intervention: Traditional packing dressings
Number of subjects: 47
Study 8952125 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle tense release
Number of subjects: 30
Study 8952125 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle stretch release
Number of subjects: 30
Study 8952125 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive relaxation procedures
Number of subjects: 30
Study 8952125 — intervention group
Group type: COMPARATOR
Intervention: Placebo attention
Number of subjects: 30
Study 8952125 — intervention group
Group type: COMPARATOR
Intervention: Test only control
Number of subjects: 30
Study 2009249 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment (beta-blockers or diuretics)
Number of subjects: 2000
Study 2009249 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2000
Study 7074750 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 40 mg every 6 hours
Number of subjects: 10
Study 7074750 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 80 mg every 6 hours
Number of subjects: 10
Study 7074750 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 50 mg every 6 hours
Number of subjects: 10
Study 7074750 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 100 mg every 6 hours
Number of subjects: 10
Study 7074750 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31732852 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral moisturizing jelly (OMJ)
Number of subjects: 62
Study 31732852 — intervention group
Group type: COMPARATOR
Intervention: Topical saliva gel (GC)
Number of subjects: 62
Study 28844754 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular testosterone enanthate 2 mg/kg (group 2b)
Number of subjects: 200
Study 28248037 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact lithotripsy (URS)
Number of subjects: 100
Study 28248037 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave lithotripsy (ESWL)
Number of subjects: 100